| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |